Investment Strategies Amid Economic Shifts

This chapter examines the divergent investment approaches during thriving versus recessionary periods, highlighting the biotech industry's current struggles with funding. It reflects on historical lessons from the dot-com era to articulate the present challenges faced by companies navigating cash flow issues and high valuations. The discussion also addresses venture capital dynamics, contrasting abundant funds with the need for prudent allocation amidst a risk-averse investment landscape.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app